{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-003483","form_type":"8-K","ticker":null,"cik":"0001556263","company_name":"Syros Pharmaceuticals, Inc.","filed_at":"2025-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.982673+00:00","generated_at":"2026-05-28T06:38:28.042707+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Syros receives Nasdaq deficiency notices for bid price, market value of listed securities, and publicly held shares","bullets":["Bid price closed below $1.00 for 35 consecutive days; 180-day cure period until July 7, 2025.","Minimum Value of Listed Securities (MVLS) below $50M for 30 consecutive business days.","Market Value of Publicly Held Shares (MVPHS) below $15M for 35 consecutive business days.","To regain compliance, stock must close at $1.00+ for 10 days; MVLS at $50M+; MVPHS at $15M+.","May transfer to Nasdaq Capital Market or appeal delisting if non-compliance continues."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-003483","json":"https://secwatch.observer/filing/0001193125-25-003483.json","markdown":"https://secwatch.observer/filing/0001193125-25-003483.md","text":"https://secwatch.observer/filing/0001193125-25-003483.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1556263/000119312525003483/0001193125-25-003483-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1556263/000119312525003483/d854734d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T06:38:28.042707+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eadb04041e7cbfe83e74f3ba672bfe09818f5921","claim":"Syros Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(2)(C)).","evidence_excerpt":"January 6, 2025, Syros Pharmaceuticals, Inc. (“ Syros ”) received deficiency letters (the “ Notices ”) from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“ Nasdaq ”) notifying Syros that: • for the last 35 consecutive business days, the bid price for Syros’ common stock has closed below $1.00 per share, which is the minimum bid price required to maintain continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1) (the “ Minimum Bid Requirement ”); • for the last 30 consecutive business days, the Minimum Value of Listed Securities, as defin","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1556263/000119312525003483/0001193125-25-003483-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5450(b)(2)(A), 5450(b)(2)(C)"}],"fact_type":"exchange_compliance_notice"},{"claim_id":"f64f1e039c989a5b8138fe01692433e5e43b4040","claim":"Syros Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).","evidence_excerpt":"January 6, 2025, Syros Pharmaceuticals, Inc. (“ Syros ”) received deficiency letters (the “ Notices ”) from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“ Nasdaq ”) notifying Syros that: • for the last 35 consecutive business days, the bid price for Syros’ common stock has closed below $1.00 per share, which is the minimum bid price required to maintain continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1) (the “ Minimum Bid Requirement ”); • for the last 30 consecutive business days, the Minimum Value of Listed Securities, as defin","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1556263/000119312525003483/0001193125-25-003483-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5450(a)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}